N/A
Average AnalystN/A
Top AnalystSlightly Bearish
Stock Target AdvisorN/A
Average UserUSD 0.07
0.00 (0.00)%
N/A
19.00
USD -1.00
Symbol | Name | Exchange | CJREF's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
VanEck Pharmaceutical ETF | NSD | 5.18 % | 0.36 % | +0.50 (+0.57%) | USD0.62B |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
This stock has shown below median revenue growth in the previous 5 years compared to its sector